Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1457967

Cover Image

PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1457967

Hearing Aids Market Size and Share Report by Product (Hearing Aid Devices, Hearing Implants), Patient type (Adults, Pediatrics), Hearing Loss (Sensorineural, Conductive), Technology (Conventional, Digital) - Global Industry Growth Forecast to 2030

PUBLISHED:
PAGES: 250 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4900
Printable PDF (Group User License)
USD 6400
Printable PDF (Enterprise License)
USD 8400

Add to Cart

The hearing aids market achieved a value of USD 8,210.5 million in 2023 and is projected to grow to USD 12,541.9 million by 2030, exhibiting a compound annual growth rate (CAGR) of 6.4% between 2024 and 2030.

This growth of the market can be credited to the growing occurrence of hearing loss, the increasing elderly populace, which is vulnerable to hearing disorders; rising knowledge about technically advanced tools for the treatment of deafness and hearing loss, and also rising binaural fitting rate.

Market Drivers

Moreover, the arrival of enhanced technologies, like wirelessly linked devices with phones, is projected to impact the industry positively.

Also, the need for cochlear implants is progressively growing, particularly among kids.

As per the WHO's data, by 2050, around 2.5 billion individuals will have some kind of hearing loss, 2 in 20 individuals will have incapacitating hearing loss, and at least 800 million will need hearing therapy.

Additionally, because of risky listening habits, approximately 1 billion kids are in danger of evolving permanent, but avoidable hearing loss.

Improvements in Hearing Aid Technology

The integration of smart technologies and digital platforms with compact devices can help in improving the hearing experience for patients.

With Phonak's Paradise technology integrated into its Virto lineup of individual hearing aid devices in February 2022.

The private Virto P-Titanium bespoke titanium in-the-ear hearing aid completes this package.

The VitoP Black is a hybrid in-the-ear hearing aid that also resembles today's earbuds.

Growing Elderly Populace

The development in the worldwide elderly populace is also among the key reasons accountable for the growing occurrence of hearing issues. Apart from age, the rising contact with loud noises, hereditary susceptibility, and physiological aging of the ears might all pay to hear the loss in the aging populace.

To be more specific, based on WHO forecasts, around 14.9% of the global population will be aged 60+ by 2030.

Data from the UNFAO said that the number of the population aged 60 years and above would expand pretty fast. They were saying that the number in 2020 was around 1 billion and it will keep on growing to 1.4 billion.

Adults Category Is Leading the Market

In recent years, on the basis of patient type, the adult category led the industry, with 70% revenue, and the category is also estimated to show extraordinary development over the projection period.

Hearing aids are widely considered the main treatment option for hearing loss problems, leading to a surge in demand for these devices.

The increasing elderly population and rising awareness about the diverse range of hearing devices and implants in the market are key factors propelling market growth.

Technologically advanced devices are being embraced by elderly individuals due to their advantages and user-friendly features.

Sensorineural Hearing Loss Category Is Anticipated to Capture the Largest Share of The Market

In 2023, on the basis of type of hearing loss, the sensorineural hearing loss category had the largest industry share 75%, and it is estimated to showcase substantial development over the projection period.

Geriatrics are a substantial subsection of the total patient pool due to their high susceptibility to sensorineural hearing loss.

Elderly patients who have mild-to-moderate SNHS in both ears can benefit from hearing aids.

Europe Is Leading the Industry

In 2023, the European region held the largest share, of approximately 40%, and the region is also projected to advance at a robust CAGR over the projection period. This can be credited to the surge in the count of people with hearing loss and government rules that are helpful for assistive listening devices. Moreover, effective government steps to enlarge access to medicinal devices are estimated to boost the hearing aids industry sales revenue in the European region.

Product Code: 10540

Table of Contents

Chapter 1. Research Scope

  • 1.1. Research Objectives
  • 1.2. Market Definition
  • 1.3. Analysis Period
  • 1.4. Market Size Breakdown by Segments
    • 1.4.1. Market size breakdown, by product
    • 1.4.2. Market size breakdown, by patient type
    • 1.4.3. Market size breakdown, by type of hearing loss
    • 1.4.4. Market size breakdown, by technology
    • 1.4.5. Market size breakdown, by region
    • 1.4.6. Market size breakdown, by country
  • 1.5. Market Data Reporting Unit
    • 1.5.1. Volume
    • 1.5.2. Value
  • 1.6. Key Stakeholders

Chapter 2. Research Methodology

  • 2.1. Secondary Research
    • 2.1.1. Paid
    • 2.1.2. Unpaid
    • 2.1.3. P&S Intelligence database
  • 2.2. Primary Research
  • 2.3. Market Size Estimation
  • 2.4. Data Triangulation
  • 2.5. Currency Conversion Rates
  • 2.6. Assumptions for the Study
  • 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

  • 5.1. Market Dynamics
    • 5.1.1. Trends
    • 5.1.2. Drivers
    • 5.1.3. Restraints/challenges
    • 5.1.4. Impact analysis of drivers/restraints
  • 5.2. Impact of COVID-19
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Bargaining power of buyers
    • 5.3.2. Bargaining power of suppliers
    • 5.3.3. Threat of new entrants
    • 5.3.4. Intensity of rivalry
    • 5.3.5. Threat of substitutes

Chapter 6. Global Market

  • 6.1. Overview
  • 6.2. Market Volume, by Product (2017-2030)
  • 6.3. Market Revenue, by Product (2017-2030)
  • 6.4. Market Volume, by Patient Type (2017-2030)
  • 6.5. Market Revenue, by Patient Type (2017-2030)
  • 6.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 6.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 6.8. Market Volume, by Technology (2017-2030)
  • 6.9. Market Revenue, by Technology (2017-2030)
  • 6.10. Market Volume, by Region (2017-2030)
  • 6.11. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

  • 7.1. Overview
  • 7.2. Market Volume, by Product (2017-2030)
  • 7.3. Market Revenue, by Product (2017-2030)
  • 7.4. Market Volume, by Patient Type (2017-2030)
  • 7.5. Market Revenue, by Patient Type (2017-2030)
  • 7.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 7.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 7.8. Market Volume, by Technology (2017-2030)
  • 7.9. Market Revenue, by Technology (2017-2030)
  • 7.10. Market Volume, by Country (2017-2030)
  • 7.11. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

  • 8.1. Overview
  • 8.2. Market Volume, by Product (2017-2030)
  • 8.3. Market Revenue, by Product (2017-2030)
  • 8.4. Market Volume, by Patient Type (2017-2030)
  • 8.5. Market Revenue, by Patient Type (2017-2030)
  • 8.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 8.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 8.8. Market Volume, by Technology (2017-2030)
  • 8.9. Market Revenue, by Technology (2017-2030)
  • 8.10. Market Volume, by Country (2017-2030)
  • 8.11. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

  • 9.1. Overview
  • 9.2. Market Volume, by Product (2017-2030)
  • 9.3. Market Revenue, by Product (2017-2030)
  • 9.4. Market Volume, by Patient Type (2017-2030)
  • 9.5. Market Revenue, by Patient Type (2017-2030)
  • 9.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 9.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 9.8. Market Volume, by Technology (2017-2030)
  • 9.9. Market Revenue, by Technology (2017-2030)
  • 9.10. Market Volume, by Country (2017-2030)
  • 9.11. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

  • 10.1. Overview
  • 10.2. Market Volume, by Product (2017-2030)
  • 10.3. Market Revenue, by Product (2017-2030)
  • 10.4. Market Volume, by Patient Type (2017-2030)
  • 10.5. Market Revenue, by Patient Type (2017-2030)
  • 10.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 10.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 10.8. Market Volume, by Technology (2017-2030)
  • 10.9. Market Revenue, by Technology (2017-2030)
  • 10.10. Market Volume, by Country (2017-2030)
  • 10.11. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

  • 11.1. Overview
  • 11.2. Market Volume, by Product (2017-2030)
  • 11.3. Market Revenue, by Product (2017-2030)
  • 11.4. Market Volume, by Patient Type (2017-2030)
  • 11.5. Market Revenue, by Patient Type (2017-2030)
  • 11.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 11.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 11.8. Market Volume, by Technology (2017-2030)
  • 11.9. Market Revenue, by Technology (2017-2030)
  • 11.10. Market Volume, by Country (2017-2030)
  • 11.11. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

  • 12.1. Overview
  • 12.2. Market Volume, by Product (2017-2030)
  • 12.3. Market Revenue, by Product (2017-2030)
  • 12.4. Market Volume, by Patient Type (2017-2030)
  • 12.5. Market Revenue, by Patient Type (2017-2030)
  • 12.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 12.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 12.8. Market Volume, by Technology (2017-2030)
  • 12.9. Market Revenue, by Technology (2017-2030)

Chapter 13. Canada Market

  • 13.1. Overview
  • 13.2. Market Volume, by Product (2017-2030)
  • 13.3. Market Revenue, by Product (2017-2030)
  • 13.4. Market Volume, by Patient Type (2017-2030)
  • 13.5. Market Revenue, by Patient Type (2017-2030)
  • 13.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 13.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 13.8. Market Volume, by Technology (2017-2030)
  • 13.9. Market Revenue, by Technology (2017-2030)

Chapter 14. Germany Market

  • 14.1. Overview
  • 14.2. Market Volume, by Product (2017-2030)
  • 14.3. Market Revenue, by Product (2017-2030)
  • 14.4. Market Volume, by Patient Type (2017-2030)
  • 14.5. Market Revenue, by Patient Type (2017-2030)
  • 14.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 14.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 14.8. Market Volume, by Technology (2017-2030)
  • 14.9. Market Revenue, by Technology (2017-2030)

Chapter 15. France Market

  • 15.1. Overview
  • 15.2. Market Volume, by Product (2017-2030)
  • 15.3. Market Revenue, by Product (2017-2030)
  • 15.4. Market Volume, by Patient Type (2017-2030)
  • 15.5. Market Revenue, by Patient Type (2017-2030)
  • 15.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 15.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 15.8. Market Volume, by Technology (2017-2030)
  • 15.9. Market Revenue, by Technology (2017-2030)

Chapter 16. U.K. Market

  • 16.1. Overview
  • 16.2. Market Volume, by Product (2017-2030)
  • 16.3. Market Revenue, by Product (2017-2030)
  • 16.4. Market Volume, by Patient Type (2017-2030)
  • 16.5. Market Revenue, by Patient Type (2017-2030)
  • 16.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 16.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 16.8. Market Volume, by Technology (2017-2030)
  • 16.9. Market Revenue, by Technology (2017-2030)

Chapter 17. Italy Market

  • 17.1. Overview
  • 17.2. Market Volume, by Product (2017-2030)
  • 17.3. Market Revenue, by Product (2017-2030)
  • 17.4. Market Volume, by Patient Type (2017-2030)
  • 17.5. Market Revenue, by Patient Type (2017-2030)
  • 17.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 17.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 17.8. Market Volume, by Technology (2017-2030)
  • 17.9. Market Revenue, by Technology (2017-2030)

Chapter 18. Spain Market

  • 18.1. Overview
  • 18.2. Market Volume, by Product (2017-2030)
  • 18.3. Market Revenue, by Product (2017-2030)
  • 18.4. Market Volume, by Patient Type (2017-2030)
  • 18.5. Market Revenue, by Patient Type (2017-2030)
  • 18.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 18.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 18.8. Market Volume, by Technology (2017-2030)
  • 18.9. Market Revenue, by Technology (2017-2030)

Chapter 19. Japan Market

  • 19.1. Overview
  • 19.2. Market Volume, by Product (2017-2030)
  • 19.3. Market Revenue, by Product (2017-2030)
  • 19.4. Market Volume, by Patient Type (2017-2030)
  • 19.5. Market Revenue, by Patient Type (2017-2030)
  • 19.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 19.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 19.8. Market Volume, by Technology (2017-2030)
  • 19.9. Market Revenue, by Technology (2017-2030)

Chapter 20. China Market

  • 20.1. Overview
  • 20.2. Market Volume, by Product (2017-2030)
  • 20.3. Market Revenue, by Product (2017-2030)
  • 20.4. Market Volume, by Patient Type (2017-2030)
  • 20.5. Market Revenue, by Patient Type (2017-2030)
  • 20.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 20.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 20.8. Market Volume, by Technology (2017-2030)
  • 20.9. Market Revenue, by Technology (2017-2030)

Chapter 21. India Market

  • 21.1. Overview
  • 21.2. Market Volume, by Product (2017-2030)
  • 21.3. Market Revenue, by Product (2017-2030)
  • 21.4. Market Volume, by Patient Type (2017-2030)
  • 21.5. Market Revenue, by Patient Type (2017-2030)
  • 21.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 21.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 21.8. Market Volume, by Technology (2017-2030)
  • 21.9. Market Revenue, by Technology (2017-2030)

Chapter 22. Australia Market

  • 22.1. Overview
  • 22.2. Market Volume, by Product (2017-2030)
  • 22.3. Market Revenue, by Product (2017-2030)
  • 22.4. Market Volume, by Patient Type (2017-2030)
  • 22.5. Market Revenue, by Patient Type (2017-2030)
  • 22.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 22.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 22.8. Market Volume, by Technology (2017-2030)
  • 22.9. Market Revenue, by Technology (2017-2030)

Chapter 23. South Korea Market

  • 23.1. Overview
  • 23.2. Market Volume, by Product (2017-2030)
  • 23.3. Market Revenue, by Product (2017-2030)
  • 23.4. Market Volume, by Patient Type (2017-2030)
  • 23.5. Market Revenue, by Patient Type (2017-2030)
  • 23.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 23.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 23.8. Market Volume, by Technology (2017-2030)
  • 23.9. Market Revenue, by Technology (2017-2030)

Chapter 24. Brazil Market

  • 24.1. Overview
  • 24.2. Market Volume, by Product (2017-2030)
  • 24.3. Market Revenue, by Product (2017-2030)
  • 24.4. Market Volume, by Patient Type (2017-2030)
  • 24.5. Market Revenue, by Patient Type (2017-2030)
  • 24.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 24.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 24.8. Market Volume, by Technology (2017-2030)
  • 24.9. Market Revenue, by Technology (2017-2030)

Chapter 25. Mexico Market

  • 25.1. Overview
  • 25.2. Market Volume, by Product (2017-2030)
  • 25.3. Market Revenue, by Product (2017-2030)
  • 25.4. Market Volume, by Patient Type (2017-2030)
  • 25.5. Market Revenue, by Patient Type (2017-2030)
  • 25.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 25.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 25.8. Market Volume, by Technology (2017-2030)
  • 25.9. Market Revenue, by Technology (2017-2030)

Chapter 26. Saudi Arabia Market

  • 26.1. Overview
  • 26.2. Market Volume, by Product (2017-2030)
  • 26.3. Market Revenue, by Product (2017-2030)
  • 26.4. Market Volume, by Patient Type (2017-2030)
  • 26.5. Market Revenue, by Patient Type (2017-2030)
  • 26.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 26.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 26.8. Market Volume, by Technology (2017-2030)
  • 26.9. Market Revenue, by Technology (2017-2030)

Chapter 27. South Africa Market

  • 27.1. Overview
  • 27.2. Market Volume, by Product (2017-2030)
  • 27.3. Market Revenue, by Product (2017-2030)
  • 27.4. Market Volume, by Patient Type (2017-2030)
  • 27.5. Market Revenue, by Patient Type (2017-2030)
  • 27.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 27.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 27.8. Market Volume, by Technology (2017-2030)
  • 27.9. Market Revenue, by Technology (2017-2030)

Chapter 28. U.A.E. Market

  • 28.1. Overview
  • 28.2. Market Volume, by Product (2017-2030)
  • 28.3. Market Revenue, by Product (2017-2030)
  • 28.4. Market Volume, by Patient Type (2017-2030)
  • 28.5. Market Revenue, by Patient Type (2017-2030)
  • 28.6. Market Volume, by Type of Hearing Loss (2017-2030)
  • 28.7. Market Revenue, by Type of Hearing Loss (2017-2030)
  • 28.8. Market Volume, by Technology (2017-2030)
  • 28.9. Market Revenue, by Technology (2017-2030)

Chapter 29. Competitive Landscape

  • 29.1. List of Market Players and their Offerings
  • 29.2. Competitive Benchmarking of Key Players
  • 29.3. Product Benchmarking of Key Players
  • 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

  • 30.1. Audina Hearing Instruments Inc.
    • 30.1.1. Business overview
    • 30.1.2. Product and service offerings
    • 30.1.3. Key financial summary
  • 30.2. Amplifon SpA
    • 30.2.1. Business overview
    • 30.2.2. Product and service offerings
    • 30.2.3. Key financial summary
  • 30.3. GN Group
    • 30.3.1. Business overview
    • 30.3.2. Product and service offerings
    • 30.3.3. Key financial summary
  • 30.4. Horentek Hearing Diagnostics
    • 30.4.1. Business overview
    • 30.4.2. Product and service offerings
    • 30.4.3. Key financial summary
  • 30.5. Cochlear Ltd.
    • 30.5.1. Business overview
    • 30.5.2. Product and service offerings
    • 30.5.3. Key financial summary
  • 30.6. Abbott Laboratories
    • 30.6.1. Business overview
    • 30.6.2. Product and service offerings
    • 30.6.3. Key financial summary
  • 30.7. Sonova Holding AG
    • 30.7.1. Business overview
    • 30.7.2. Product and service offerings
    • 30.7.3. Key financial summary
  • 30.8. Sivantos Group
    • 30.8.1. Business overview
    • 30.8.2. Product and service offerings
    • 30.8.3. Key financial summary
  • 30.9. EunSung
    • 30.9.1. Business overview
    • 30.9.2. Product and service offerings
    • 30.9.3. Key financial summary
  • 30.10. Arphi Electronics Private Limited
    • 30.10.1. Business overview
    • 30.10.2. Product and service offerings
    • 30.10.3. Key financial summary

Chapter 31. Appendix

  • 31.1. Abbreviations
  • 31.2. Sources and References
  • 31.3. Related Reports
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!